<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35994135</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Autonomic and neuropathic complaints of long-COVID objectified: an investigation from electrophysiological perspective.</ArticleTitle><Pagination><StartPage>6167</StartPage><EndPage>6177</EndPage><MedlinePgn>6167-6177</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-022-06350-y</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Here , we aimed to assess the frequency and phenomenology of autonomic and neuropathic complaints of long-COVID and to evaluate them by means of electrophysiology.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Step 1. Patients with prior COVID-19 infection were screened by COMPASS-31 and mTORONTO to create the target population for further evaluation. Step 2. Patients with high scores were invited for a detailed history of their complaints and electrophysiological analysis, which included nerve conduction studies, cutaneous silent period (CSP), and sympathetic skin response (SSR). We also constituted a control group composed of healthy subjects of similar age and sex for electrophysiological analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 106 patients, who matched the study criteria. Among them, thirty-eight patients (%35.8) had neuropathic or autonomic complaints or both. Fatigue and headache were significantly more frequent in patients with autonomic and neuropathic complaints. Detailed examination and electrophysiological evaluation were performed in 14 of 38 patients. Neuropathic complaints were patchy and proximally located in the majority. The entire CSP suppression index was higher in the patients (p&#x2009;=&#x2009;0.002). There was no difference in palmar and plantar SSR between patients and healthy subjects. mTORONTO scores were negatively correlated with palmar and plantar SSR amplitudes, and the correlation was moderate.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Neuropathic or autonomic complaints were seen in more than one-third of patients with long-COVID. Neuropathic complaints were generally patchy, proximally predominant, asymmetric, or diffuse. The CSP suppression index was abnormal whereas SSRs were normal.</AbstractText><CopyrightInformation>&#xa9; 2022. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ser</LastName><ForeName>Merve Hazal</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;al&#x131;ku&#x15f;u</LastName><ForeName>Fatma Zehra</ForeName><Initials>FZ</Initials><Identifier Source="ORCID">0000-0002-6644-6553</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. zehra.calikusu@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanr&#x131;verdi</LastName><ForeName>Uygur</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbaszade</LastName><ForeName>Hikmet</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakyemez</LastName><ForeName>Sena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Kocamustafapasa Street No: 53 Fatih, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balkan</LastName><ForeName>&#x130;lker &#x130;nan&#xe7;</ForeName><Initials>&#x130;&#x130;</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Kocamustafapasa Street No: 53 Fatih, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karaali</LastName><ForeName>R&#x131;dvan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Kocamustafapasa Street No: 53 Fatih, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nd&#xfc;z</LastName><ForeName>Ay&#x15f;eg&#xfc;l</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001341" MajorTopicYN="N">Autonomic Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005712" MajorTopicYN="N">Galvanic Skin Response</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003929" MajorTopicYN="Y">Diabetic Neuropathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="N">innervation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autonomic function</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cutaneous silent period</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Neuropathic complaints</Keyword><Keyword MajorTopicYN="N">Sympathetic skin response</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>22</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35994135</ArticleId><ArticleId IdType="pmc">PMC9395948</ArticleId><ArticleId IdType="doi">10.1007/s10072-022-06350-y</ArticleId><ArticleId IdType="pii">10.1007/s10072-022-06350-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12:372. doi: 10.3390/v12040372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12040372</ArticleId><ArticleId IdType="pmc">PMC7232198</ArticleId><ArticleId IdType="pubmed">32230900</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen NW, Stiles LE, Miglis MG. Preparing for the long-haul: autonomic complications of COVID-19. Auton Neurosci. 2021;235:102841. doi: 10.1016/j.autneu.2021.102841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102841</ArticleId><ArticleId IdType="pmc">PMC8254396</ArticleId><ArticleId IdType="pubmed">34265539</ArticleId></ArticleIdList></Reference><Reference><Citation>(2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence (NICE),&#xa0;London</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim EJ, Son CG. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J Transl Med. 2020;18:289. doi: 10.1186/s12967-020-02455-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType="pmc">PMC7391812</ArticleId><ArticleId IdType="pubmed">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, et al (2021) Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19 51:1107&#x2013;1120</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Agergaard J, Leth S, Pedersen TH, Harbo T, Blicher JU, Karlsson P, &#xd8;stergaard L, Andersen H, Tankisi H (2021) Myopathic changes in patients with long-term fatigue after COVID-19. Clin Neurophysiol 132(8):1974&#x2013;1981. 10.1016/j.clinph.2021.04.009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8102077</ArticleId><ArticleId IdType="pubmed">34020890</ArticleId></ArticleIdList></Reference><Reference><Citation>Murga I, Aranburu L, Gargiulo PA, G&#xf3;mez Esteban JC, Lafuente JV. Clinical heterogeneity in ME/CFS A way to understand long-COVID19 fatigue. Front Psychiatry. 2021;12:735784. doi: 10.3389/fpsyt.2021.735784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.735784</ArticleId><ArticleId IdType="pmc">PMC8542754</ArticleId><ArticleId IdType="pubmed">34707521</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite Stella A, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study. J Neurol. 2022;269:587&#x2013;596. doi: 10.1007/s00415-021-10735-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, Claydon VE, Limberg JK, Lucci VM, Numan M, Peltier A, Snapper H, Vernino S. American Autonomic Society. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31:365&#x2013;368. doi: 10.1007/s10286-021-00798-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellavia S, Scala I, Luigetti M, Brunetti V, Gabrielli M, Zileri Dal Verme L, Servidei S, Calabresi P, Frisullo G, Della Marca G. Instrumental evaluation of COVID-19 related dysautonomia in non-critically-ill patients: an observational, cross-sectional study. J Clin Med. 2021;10:5861. doi: 10.3390/jcm10245861.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245861</ArticleId><ArticleId IdType="pmc">PMC8703676</ArticleId><ArticleId IdType="pubmed">34945155</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinduja A, Moutairou A, Calvet JH. Sudomotor dysfunction in patients recovered from COVID-19. Neurophysiol Clin. 2021;51:193&#x2013;196. doi: 10.1016/j.neucli.2021.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2021.01.003</ArticleId><ArticleId IdType="pmc">PMC7835104</ArticleId><ArticleId IdType="pubmed">33551341</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. 2022;65:440&#x2013;443. doi: 10.1002/mus.27458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc. 2012;87:1196&#x2013;1201. doi: 10.1016/j.mayocp.2012.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.10.013</ArticleId><ArticleId IdType="pmc">PMC3541923</ArticleId><ArticleId IdType="pubmed">23218087</ArticleId></ArticleIdList></Reference><Reference><Citation>Bril V, Tomioka S, Buchanan RA, Perkins BA, the mTCNS Study Group Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy. Diabet Med. 2009;26:240&#x2013;246. doi: 10.1111/j.1464-5491.2009.02667.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-5491.2009.02667.x</ArticleId><ArticleId IdType="pmc">PMC2871179</ArticleId><ArticleId IdType="pubmed">19317818</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121&#x2013;1123. doi: 10.1001/archneur.1989.00520460115022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura J. Electrodiagnosis in diseases of nerve and muscle. New York: Principles and practice Oxford University Press; 2006.</Citation></Reference><Reference><Citation>Kofler M. Functional organization of exteroceptive inhibition following nociceptive electrical fingertip stimulation in humans. Clin Neurophysiol. 2003;114:973&#x2013;980. doi: 10.1016/S1388-2457(03)00060-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1388-2457(03)00060-9</ArticleId><ArticleId IdType="pubmed">12804665</ArticleId></ArticleIdList></Reference><Reference><Citation>Kofler M, Kumru H, Stetkarova I, Schindler C, Fuhr P. Muscle force up to 50% of maximum does not affect cutaneous silent periods in thenar muscles. Clin Neurophysiol. 2007;118:2025&#x2013;2030. doi: 10.1016/j.clinph.2007.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.06.005</ArticleId><ArticleId IdType="pubmed">17644035</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumru H, Opisso E, Valls-Sol&#xe9; J, Kofler M. The effect of a prepulse stimulus on the EMG rebound following the cutaneous silent period. J Physiol. 2009;587:587&#x2013;595. doi: 10.1113/jphysiol.2008.164186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2008.164186</ArticleId><ArticleId IdType="pmc">PMC2670082</ArticleId><ArticleId IdType="pubmed">19064615</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell ML, Catalfamo CJ, Farland LV, et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS ONE. 2021;16:e0254347. doi: 10.1371/journal.pone.0254347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Scala I, Bellavia S, Luigetti M, et al. Autonomic dysfunction in non-critically ill COVID-19 patients during the acute phase of disease: an observational, cross-sectional study. Neurol Sci. 2022;24:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127042</ArticleId><ArticleId IdType="pubmed">35608736</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, Sandroni P, Benarroch EE, Berini SE, Cutsforth-Gregory JK, Coon EA, Mauermann ML, Low PA, Singer W. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31:385&#x2013;394. doi: 10.1007/s10286-021-00803-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucera P, Goldenberg Z, Kurca E. Sympathetic skin response: review of the method and its clinical use. Bratisl Lek Listy. 2004;105:108&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">15253529</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, Mills AJ, Kelley M, Toran LS, Smith B, Dalakas MC, Nath A. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm. 2022;9:e1146. doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemignani F, Bellanova MF, Saccani E, Pavesi G. Non-length-dependent small fiber neuropathy: not a matter of stockings and gloves. Muscle Nerve. 2022;65:10&#x2013;28. doi: 10.1002/mus.27379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27379</ArticleId><ArticleId IdType="pubmed">34374103</ArticleId></ArticleIdList></Reference><Reference><Citation>Mota IA, Fernandes JB, Cardoso MN, Sala-Blanch X, Kofler M, Valls-Sol&#xe9; J. Temporal profile of the effects of regional anesthesia on the cutaneous reflexes of foot muscles. Exp Brain Res. 2015;233:2587&#x2013;2596. doi: 10.1007/s00221-015-4329-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-015-4329-2</ArticleId><ArticleId IdType="pubmed">26025613</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrao M, Parisi L, Pierelli F, Rossi P. Cutaneous afferents mediating the cutaneous silent period in the upper limbs: evidences for a role of low-threshold sensory fibres. Clin Neurophysiol. 2001;112:2007&#x2013;2014. doi: 10.1016/S1388-2457(01)00675-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1388-2457(01)00675-7</ArticleId><ArticleId IdType="pubmed">11682338</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Logigian EL. The mixed nerve silent period in normal subjects and patients with amyotrophic lateral sclerosis. Electromyogr Clin Neurophysiol. 1998;38:505&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">9842486</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro J, Swash M, de Carvalho M. The cutaneous silent period in motor neuron disease. Clin Neurophysiol. 2021;132:660&#x2013;665. doi: 10.1016/j.clinph.2020.10.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.10.033</ArticleId><ArticleId IdType="pubmed">33358125</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayd&#x131;n &#x15e;, Kofler M, Bakuy Y, G&#xfc;nd&#xfc;z A, K&#x131;z&#x131;ltan ME. Effects of vibration on cutaneous silent period. Exp Brain Res. 2019;237:911&#x2013;918. doi: 10.1007/s00221-018-05463-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-018-05463-1</ArticleId><ArticleId IdType="pubmed">30659303</ArticleId></ArticleIdList></Reference><Reference><Citation>Provitera V, Gibbons CH, Wendelschafer-Crabb G, Donadio V, Vitale DF, Loavenbruck A, Stancanelli A, Caporaso G, Liguori R, Wang N, Santoro L, Kennedy WR, Nolano M. The role of skin biopsy in differentiating small-fiber neuropathy from ganglionopathy. Eur J Neurol. 2018;25:848&#x2013;853. doi: 10.1111/ene.13608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13608</ArticleId><ArticleId IdType="pubmed">29493845</ArticleId></ArticleIdList></Reference><Reference><Citation>Kofler M, Leis AA, Valls-Sol&#xe9; J. Cutaneous silent periods - part 1: update on physiological mechanisms. Clin Neurophysiol. 2019;130:588&#x2013;603. doi: 10.1016/j.clinph.2019.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.01.002</ArticleId><ArticleId IdType="pubmed">30691969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kofler M, Leis AA, Valls-Sol&#xe9; J. Cutaneous silent periods - part 2: update on pathophysiology and clinical utility. Clin Neurophysiol. 2019;130:604&#x2013;615. doi: 10.1016/j.clinph.2019.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.01.003</ArticleId><ArticleId IdType="pubmed">30704842</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>